Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease

Journal of Magnetic Resonance Imaging

Volumn 6, Issue 6, 1996, Pages 889-893

  Wittsack, H J ^a   Kugel, Harald ^a   Roth, B ^a   Heindel, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Brain; Canavan's disease; Central nervous system; Children; Metabolism; MR spectroscopy; N Acetylaspartic acid; Proton spectroscopy; Quantitation

Indexed keywords

ASPARTIC ACID; CHOLINE; DRUG DERIVATIVE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ARTICLE; BRAIN; CANAVAN DISEASE; CASE REPORT; COMPARATIVE STUDY; FEMALE; HUMAN; INFANT; INSTRUMENTATION; MALE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE VALUE;

ASPARTIC ACID; BRAIN; CANAVAN DISEASE; CHOLINE; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REFERENCE VALUES;

EID: 0030280604     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880060609     Document Type: Article

References (28)

1. Canavan M. Schilder's encephalitu periarialu diffusa. Arch Neurol Psychiatry 1931; 25:299-308.
2. Van Bogaert L, Bertrand I. Sur une idiotie familiale avec dégénérescence spongieuse du evraxe (note préliminaire). Acta Neurol Belg 1947; 49:572-587.
3. Bartalini G, Margollicci M, Balestri P, Farnetani MA, Cioni M, Fois A. Biochemical diagnosis of Canavan disease. Childs Nerv Syst 1992; 8:468-470.
4. Valk J, van der Knaap MS, eds. Magnetic resonance of myelin, myelination, and myelin disorders. New York: Springer Verlag, 1989; 137-140.
5. 1H NMR spectroscopy of cerebrospinal fluid and urine in Canavan's disease. In: Book of abstracts: Society of Magnetic Resonance in Medicine 1992. Berlin, Germany: Society of Magnetic Resonance in Medicine, 1992; 3416.
6. Echenne B, Divry P, Vianey-Liaud C. Spongy degeneration of the neuroaxis (Canavan-van Bogaert disease) and N-acetylaspartatic aciduria. Neuropediatrics 1989; 20:79-81.
7. Matalon R, Michals K, Sebesta D, Deanching M, Gashkoff P, Casanova J. Aspartoacylase deficiency and N-acetylaspartatic aciduria in patients with Canavan disease. Am J Med Genet 1988; 29:463.
8. Kvittingen EA, Guldal E, Borsting S, Skalpe EO, Stokke O, Jellum E. N-acetylaspartic aciduria in a child with a progressive cerebral atrophy. Clin Chim Acta 1986; 158:217-227.
9. Barker PB, Bryan RN, Kumar AJ, Naidu S. Proton NMR spectroscopy of Canavan's disease. Neuropediatrics 1992; 23:263-267.
10. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4:47-52.
11. Bottomley P. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508:333-348.
12. 1H-MRS using water as an internal standard. Magn Reson Imaging 1993; 11:107-118.
13. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989; 11: 47-63.
14. de Beer R, van Ormondt D. Analysis of NMR data using time domain fitting procedures. In: Diehl P, Fluck E, Günther H, Kosfeld R, Seelig J, eds. NMR basic principles and progress, vol. 26. New York: Springer Verlag, 1992; 199-248.
15. van der Knaap MS. Spongy white matter changes - MRI characteristics. In: Proceedings of the 12th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1993; 1458.
16. 1H magnetic resonance spectroscopy in Canavan's disease: a case report. Ann Neurol 1990; 30:106-110.
17. Kugel H, Roth B, Heindel W, Lackner K. Proton MR spectroscopy in infants with hypoxic ischemic encephalopathy and energy deficiency syndromes. In: Proceedings of the 12th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1993; 320.
18. Toft PB, Leth H, Lou HC, Henriksen O. Brain metabolite concentrations in the neonatal and infant brain estimated by proton magnetic resonance spectroscopy. In: Proceedings of the 12th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1993; 319.
19. Dobbing J, Sands J. Quantitative growth and development of human brain. Arch Dis Child 1973; 48:757-767.
20. 1H-MRS. In: Proceedings of the 12th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1993; 126.
21. Toft PB, Geiß-Holtorff R, Rolland MO, et al. Magnetic resonance imaging in juvenile Canavan disease. Eur J Pediatr 1993; 152:750-753.
22. 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 1991; 19:439-445.
23. Grodd W, Krägeloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990; 18:437-438.
24. Hamaguchi H, Nihei K, Nakamoto N, et al. A case of Canavan disease: the first biochemically proven case in a Japanese girl. Brain Dev 1993; 15:367-371.
25. Subramanyam S, Tipirneni A, Youssef N, Gascon G, Ozand P. Biochemical heterogeneity of infantile central nervous system spongy degeneration. J Child Neurlo 1992; 7:22-25.
26. Brismar J, Brismar G, Gascon G, Ozand P. Canavan disease: CT and MR imaging of the brain. AJNR 1990; 11:805-810.
27. Bührer C, Bassir C, von Moers A, et al. Cranial ultrasound findings in aspartoacylase deficiency (Canavan disease) Pediatr Radiol 1993; 23:395-397.
28. Hagenfeldt L, Bollgren I, Venizelos N. N-acetylaspartatic aciduria due to aspartoacylase deficiency - a new aetiology of childhood leukodystrophy. J Inherit Metab Dis 1987; 10:135.